Assessment of Two Diabetes Point-of-care Analyzers Measuring Hemoglobin A1c in the Peruvian Amazon
Background: With an estimated 174 million undiagnosed cases of diabetes mellitus worldwide and 80% of them occurring in low- and middle-income countries an effective point-of-care diagnostic tool is key to fighting this global epidemic. Glycated hemoglobin has become a reliable biomarker for the dia...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Ubiquity Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/01254071bbde4e4993a610d3b7db1024 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:01254071bbde4e4993a610d3b7db1024 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:01254071bbde4e4993a610d3b7db10242021-12-02T02:59:06ZAssessment of Two Diabetes Point-of-care Analyzers Measuring Hemoglobin A1c in the Peruvian Amazon2214-999610.29024/aogh.2368https://doaj.org/article/01254071bbde4e4993a610d3b7db10242018-11-01T00:00:00Zhttps://annalsofglobalhealth.org/articles/2368https://doaj.org/toc/2214-9996Background: With an estimated 174 million undiagnosed cases of diabetes mellitus worldwide and 80% of them occurring in low- and middle-income countries an effective point-of-care diagnostic tool is key to fighting this global epidemic. Glycated hemoglobin has become a reliable biomarker for the diagnosis and prognosis of diabetes. Objective: We assessed two point-of-care (POC) analyzers in multi-ethnic communities of the Amazon Rainforest in Peru where laboratory-based glycated hemoglobin (HbA1c) testing is not available. Methods: 203 venous blood samples were tested for HbA1c by Afinion and DCA Vantage analyzers as well as a Premier Hb9210 high-performance liquid chromatography (HPLC) method as the reference standard. The coefficient of variation (CV) of each device was calculated to assess assay imprecision. Bland-Altman plots were used to assess bias. Ambient temperature, humidity, and barometric pressure were also evaluated for their effect on HbA1c results using multivariate regression. Findings: There was a wide range of HbA1c for participants based on the HPLC test: 4.4–9.0% (25–75 mmol/mol). The CV for the Afinion was 1.75%, and 4.01% for Vantage. The Afinion generated higher HbA1c results than the HPLC (mean difference = +0.56% [+6 mmol/mol]; p < 0.001), as did the DCA Vantage (mean difference = +0.32% [4 mmol/mol] p < 0.001). Temperature and humidity were not related to HbA1c; however, barometric pressure was associated with HPLC HbA1c results for the Afinion. Conclusions: Imprecision and bias were not low enough to recommend either POC analyzer for HbA1c determinations in this setting.Anthony T. SaxtonJ. Jaime MirandaErnesto J. OrtizWilliam PanUbiquity PressarticleInfectious and parasitic diseasesRC109-216Public aspects of medicineRA1-1270ENAnnals of Global Health, Vol 84, Iss 4 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Infectious and parasitic diseases RC109-216 Public aspects of medicine RA1-1270 |
spellingShingle |
Infectious and parasitic diseases RC109-216 Public aspects of medicine RA1-1270 Anthony T. Saxton J. Jaime Miranda Ernesto J. Ortiz William Pan Assessment of Two Diabetes Point-of-care Analyzers Measuring Hemoglobin A1c in the Peruvian Amazon |
description |
Background: With an estimated 174 million undiagnosed cases of diabetes mellitus worldwide and 80% of them occurring in low- and middle-income countries an effective point-of-care diagnostic tool is key to fighting this global epidemic. Glycated hemoglobin has become a reliable biomarker for the diagnosis and prognosis of diabetes. Objective: We assessed two point-of-care (POC) analyzers in multi-ethnic communities of the Amazon Rainforest in Peru where laboratory-based glycated hemoglobin (HbA1c) testing is not available. Methods: 203 venous blood samples were tested for HbA1c by Afinion and DCA Vantage analyzers as well as a Premier Hb9210 high-performance liquid chromatography (HPLC) method as the reference standard. The coefficient of variation (CV) of each device was calculated to assess assay imprecision. Bland-Altman plots were used to assess bias. Ambient temperature, humidity, and barometric pressure were also evaluated for their effect on HbA1c results using multivariate regression. Findings: There was a wide range of HbA1c for participants based on the HPLC test: 4.4–9.0% (25–75 mmol/mol). The CV for the Afinion was 1.75%, and 4.01% for Vantage. The Afinion generated higher HbA1c results than the HPLC (mean difference = +0.56% [+6 mmol/mol]; p < 0.001), as did the DCA Vantage (mean difference = +0.32% [4 mmol/mol] p < 0.001). Temperature and humidity were not related to HbA1c; however, barometric pressure was associated with HPLC HbA1c results for the Afinion. Conclusions: Imprecision and bias were not low enough to recommend either POC analyzer for HbA1c determinations in this setting. |
format |
article |
author |
Anthony T. Saxton J. Jaime Miranda Ernesto J. Ortiz William Pan |
author_facet |
Anthony T. Saxton J. Jaime Miranda Ernesto J. Ortiz William Pan |
author_sort |
Anthony T. Saxton |
title |
Assessment of Two Diabetes Point-of-care Analyzers Measuring Hemoglobin A1c in the Peruvian Amazon |
title_short |
Assessment of Two Diabetes Point-of-care Analyzers Measuring Hemoglobin A1c in the Peruvian Amazon |
title_full |
Assessment of Two Diabetes Point-of-care Analyzers Measuring Hemoglobin A1c in the Peruvian Amazon |
title_fullStr |
Assessment of Two Diabetes Point-of-care Analyzers Measuring Hemoglobin A1c in the Peruvian Amazon |
title_full_unstemmed |
Assessment of Two Diabetes Point-of-care Analyzers Measuring Hemoglobin A1c in the Peruvian Amazon |
title_sort |
assessment of two diabetes point-of-care analyzers measuring hemoglobin a1c in the peruvian amazon |
publisher |
Ubiquity Press |
publishDate |
2018 |
url |
https://doaj.org/article/01254071bbde4e4993a610d3b7db1024 |
work_keys_str_mv |
AT anthonytsaxton assessmentoftwodiabetespointofcareanalyzersmeasuringhemoglobina1cintheperuvianamazon AT jjaimemiranda assessmentoftwodiabetespointofcareanalyzersmeasuringhemoglobina1cintheperuvianamazon AT ernestojortiz assessmentoftwodiabetespointofcareanalyzersmeasuringhemoglobina1cintheperuvianamazon AT williampan assessmentoftwodiabetespointofcareanalyzersmeasuringhemoglobina1cintheperuvianamazon |
_version_ |
1718402019996205056 |